| |
| |
|
| Insider
Information: |
Gold Mitchell |
| Relationship: |
Executive Chairman and... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
457,263 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
457,263 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dendreon Corp |
DNDN |
Director |
2013-01-03 |
457,263 |
2003-09-03 |
0 |
Premium* |
|
|
Alpine Immune Sciences Inc |
ALPN |
Executive Chairman and... |
2024-05-20 |
0 |
2024-05-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-19 |
4 |
AS |
$20.01 |
$48,064 |
D/D |
(2,402) |
0 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-22 |
4 |
OE |
$0.45 |
$17,021 |
D/D |
37,825 |
37,825 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-22 |
4 |
AS |
$20.43 |
$772,595 |
D/D |
(37,825) |
0 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-26 |
4 |
OE |
$0.45 |
$15,436 |
D/D |
24,486 |
24,486 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-26 |
4 |
AS |
$20.22 |
$495,217 |
D/D |
(24,486) |
0 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-27 |
4 |
AS |
$20.04 |
$592,717 |
D/D |
(29,573) |
0 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-27 |
4 |
OE |
$0.65 |
$19,222 |
D/D |
29,573 |
29,573 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-28 |
4 |
OE |
$0.65 |
$660 |
D/D |
1,016 |
1,016 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-28 |
4 |
AS |
$20.04 |
$20,362 |
D/D |
(1,016) |
0 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-28 |
4 |
OE |
$12.74 |
$948,378 |
I/I |
74,441 |
2,675,421 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-28 |
4 |
D |
$19.65 |
$948,388 |
I/I |
(48,264) |
2,627,157 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2024-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
96,000 |
96,000 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2024-05-08 |
4 |
OE |
$7.55 |
$100,000 |
D/D |
13,245 |
109,245 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2024-05-18 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,627,157) |
0 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2024-05-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(109,245) |
0 |
0 |
- |
|
140 Records found
|
|
Page 6 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
